UNSPSC 51291501: Feprosidnine

This classification denotes an antidepressant agent with the molecular formula C11H13N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1G4W8NR1PT, chemically known as 3-(1-methyl-2-phenylethyl)sydnone imine, monohydrochloride but generally known as feprosidnine, which bears US NIH Compound Identifier 72088. European Medicines Agency schedules Feprosidnine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07609MIG.

UNSPSC 51291501 Feprosidnine, a Commodity code, does not map to the state and local procurement activity recorded in recent opportunities. Seminole County, Florida's July 2026 IFB solicitation (IFB60459723LAS) sought naloxone and safe drug deactivation systems — pharmaceutical harm-reduction supplies supporting community health initiatives — which falls outside the nominal scope of this pharmaceutical ingredient code. The source shows no other recent opportunities tagged to this code, and the single opportunity present represents a clear categorical mismatch between the code's intended use and the work actually being solicited.

State and local procurement under this code appears inactive or mistagged in the available record. The Seminole County procurement, while concrete and specific (1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida; electronic bid submission required; two-year term with one-year renewal option), does not reflect demand for feprosidnine itself. Absent additional opportunities properly aligned to this Commodity code's substance scope, the code warrants a skip unless your firm specifically manufactures or distributes feprosidnine and can establish direct relevance to state and local health or pharmaceutical procurement channels.